Landis G. Michael insider trades
Landis G. Michael has filed 1 Form 4 with the SEC that we hold, all for Polaryx Therapeutics, Inc. (PLYX), as Chief Financial Officer, Director. Across all of them we count 1 purchase worth $8.0K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($8.0K) and 0 sales ($0). The largest single trade was a purchase of 2,867 shares of Polaryx Therapeutics, Inc. worth $8.0K, dated 2026-02-18. The first filing on our record is dated 2026-02-20 and the latest 2026-02-20.
Polaryx Therapeutics, Inc. (PLYX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-18 | P, purchase reported on Form 4 | 2,867 | $8.0K | 2026-02-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1548560) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms